CDK12 inhibitors(Syros)

N/A

Report date: 2022/04/18 16:40:16

Base Information

Drug NameCDK12 inhibitors(Syros)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionCyclin-dependent kinase 12 inhibitors
TargetsCyclin-dependent kinase 12
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSyros Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyros Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A